Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Grant awarded to Cel-Sci for herpes simplex vaccine development

Oct. 11, 2000

NIAID awards grants for drug and vaccine development

Oct. 10, 2000

AstraZeneca presents new tyrosine kinase inhibitors with immunomodulating activity

Oct. 9, 2000

BioSante's CAP vaccine adjuvant completes phase I clinical trial

Oct. 6, 2000

Preclinical studies indicate potential for ISAtx-247 in diabetes treatment

Oct. 5, 2000

Mevinolin derivatives for disorders mediated by LFA-1/ICAM-1 interactions

Oct. 3, 2000

Milestone reached in MorphoSys and GPC Biotech immunology therapeutics program

Sep. 28, 2000

SangStat's Thymoglobulin granted orphan drug designation in U.S.

Sep. 26, 2000

Baxter and Peptide Therapeutics enter collaboration for vaccine development

Sep. 22, 2000

Pseudo-proline-containing ciclosporin derivatives useful as prodrugs

Sep. 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...